Skip to main content
TipRanks
Go Ultimate75% OFF

Cytokinetics (KK3A) Revenue

4 Followers

Cytokinetics Revenue

Cytokinetics had a revenue of 47.56M in the quarter ending Sep 30, 2026, with 66.14%. This bring the company's revenue in the last twelve months to 113.29M, Increased 67.42%. In the fiscal year ending Dec 31, 2025, Cytokinetics had annual revenue of 88.04M with 376.56% growth.

Revenue (ttm)
113.29M
Revenue Growth
25.43%
P/S Ratio
80.11
Revenue/Employee
EUR 130,816
Employees
673
Market Cap
EUR 7.05B

Revenue Chart

Cytokinetics Revenue - Annual

020M40M60M80M100M13.37M31.50M26.87M55.83M70.43M94.59M7.53M18.47M88.04M201720182019202020212022202320242025
Revenue History
Download to Excel
DE:KK3A revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202588.04M69.56M376.56%
Dec 31, 202418.47M10.94M145.34%
Dec 31, 20237.53M-87.06M-92.04%
Dec 31, 202294.59M24.16M34.30%
Dec 31, 202170.43M14.60M26.15%
Dec 31, 202055.83M28.96M107.79%
Dec 31, 201926.87M-4.63M-14.71%
Dec 31, 201831.50M18.13M135.64%
Dec 31, 201713.37M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
DE:KK3A113.29M
SRPT1.96B
PTCT1.16B
SRRK570.00K
DYN0.00
EWTX0.00